Skip to main content
Clinical Trials/NCT00224601
NCT00224601
Completed
Phase 2

Early Detection of Pre-cancer Lesions in Adults With Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Syndrome: Assessment of Coloscopy With Chromoscopy Benefit

Assistance Publique - Hôpitaux de Paris1 site in 1 country80 target enrollmentJuly 2005

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Colorectal Neoplasms, Hereditary Nonpolyposis
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
80
Locations
1
Primary Endpoint
Number of pre-cancer lesions or early cancer detected.
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The aim of the study is to test the hypothesis that a chromoscopy colonoscopy is able to increase by 50 % the number of pre-cancer lesions or early cancer detected in patients with HNPCC syndrome, compared to a routine colonoscopy without chromoscopy.

Detailed Description

Patient with HNPCC syndrome confirmed by a mutation (MLH1, MSH2, MHS1) are involved in the study. Patient have 2 colonoscopy back to back. The second coloscopy is associated to chromoscopy with carmin indigo. Endoscopist are randomised for the colonoscopy with chromoscopy and are un-awarded of the result of the first colonoscopy. Histopathology of the polyp are noted. The follow up were 1 month.

Registry
clinicaltrials.gov
Start Date
July 2005
End Date
January 2008
Last Updated
15 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with MLH1, MSH2 or MSH6 mutation.
  • Patients concerned by early detection colonoscopy.

Exclusion Criteria

  • Coloscopy of tracking since less 1an
  • occlusive Syndrome contra-indicating the preparation for a total coloscopies
  • Colectomies
  • medical Conditions or serious illnesses contra-indicating a coloscopy of screening
  • pregnant Woman or nursing
  • Anomaly of coagulation contra-indicating the realization of biopsies and/or the exeresis of the lesion colorectal

Outcomes

Primary Outcomes

Number of pre-cancer lesions or early cancer detected.

Time Frame: during the procedure

Secondary Outcomes

  • Anatomopathologic criteria (size of lesions, …).(during the procedure)

Study Sites (1)

Loading locations...

Similar Trials